2/28/2024

Quinapril Tablets

Products Affected - Description

- Accupril oral tablet, Pfizer, 10 mg, bottle, 90 count, NDC 00071-0530-23
- Accupril oral tablet, Pfizer, 20 mg, bottle, 90 count, NDC 00071-0532-23
- Accupril oral tablet, Pfizer, 40 mg, bottle, 90 count, NDC 00071-0535-23
- Accupril oral tablet, Pfizer, 5 mg, bottle, 90 count, NDC 00071-0527-23
- Quinapril hydrochloride oral tablet, Lupin, 10 mg, bottle, 90 count, NDC 68180-0557-09 - discontinued
- Quinapril hydrochloride oral tablet, Lupin, 20 mg, bottle, 90 count, NDC 68180-0558-09 - discontinued
- Quinapril hydrochloride oral tablet, Lupin, 40 mg, bottle, 90 count, NDC 68180-0554-09 - discontinued
- Quinapril hydrochloride oral tablet, Lupin, 5 mg, bottle, 90 count, NDC 68180-0556-09 - discontinued
- Quinapril hydrochloride oral tablet, Solco Healthcare US, 10 mg, bottle, 90 count, NDC 43547-0411-09 - discontinued
- Quinapril hydrochloride oral tablet, Solco Healthcare US, 20 mg, bottle, 90 count, NDC 43547-0412-09 - discontinued
- Quinapril hydrochloride oral tablet, Solco Healthcare US, 40 mg, bottle, 90 count, NDC 43547-0413-09 - discontinued
- Quinapril hydrochloride oral tablet, Solco Healthcare US, 5 mg, bottle, 90 count, NDC 43547-0410-09 - discontinued

Reason for the Shortage

- Lupin discontinued quinapril tablets in February 2023.
- Lupin recalled 4 lots of quinapril in December 2022 due to the presence of a nitrosamine impurity. Additional information can be found at https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-four-lots-quinapril-tablets-due
- Pfizer has all Accupril presentations on back order due to a manufacturing delay.
- Solco discontinued all quinapril tablet presentations.

Available Products

- There are no presentations available

Estimated Resupply Dates

- Pfizer has all Accupril presentations on back order and the company cannot estimate a release date.

Updated

Updated February 28, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created January 3, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.